Koers Alternate Health Corp. Canadian Securities Exchange
Aandelen
AHG
CA02090B1022
Farmaceutische producten
Omzet 2017 | 13,25 mln. 9,68 mln. 9,04 mln. | Omzet 2018 | 577K 421K 394K | Marktkapitalisatie | 22,67 mln. 16,55 mln. 15,47 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2017 | -26 mln. -18,98 mln. -17,74 mln. | Nettowinst (verlies) 2018 | -24 mln. -17,52 mln. -16,38 mln. | EV/omzet 2017 | 6,25 x |
Nettoliquiditeiten 2017 | 893K 652K 609K | Nettoliquiditeiten 2018 | 773K 564K 527K | EV/omzet 2018 | 37,9 x |
K/w-verhouding 2017 |
-3,04
x | K/w-verhouding 2018 |
-0,76
x | Werknemers | - |
Dividendrendement 2017 * |
-
| Dividendrendement 2018 |
-
| Vrij verhandelbaar | 100% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Howard Mann
FOU | Founder | - | 11-12-18 |
Director of Finance/CFO | - | 25-01-18 | |
Chairman | - | 05-04-17 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
James E. Tykoliz
BRD | Director/Board Member | - | 16-04-15 |
Chairman | - | 05-04-17 | |
Howard Mann
FOU | Founder | - | 11-12-18 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+28,10% | 5,68 mld. | |
-33,42% | 3,61 mld. | |
-3,33% | 3,11 mld. | |
-26,20% | 2,65 mld. | |
-9,99% | 2,33 mld. | |
+40,09% | 1,89 mld. | |
+40,90% | 1,49 mld. | |
-12,94% | 1,46 mld. | |
+46,67% | 1,37 mld. |